Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Cryoport, Inc. Director's Dealing 2021

Jun 30, 2021

32876_dirs_2021-06-30_913916c3-6018-409e-be2b-2da52ed39b41.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cryoport, Inc. (CYRX)
CIK: 0001124524
Period of Report: 2021-06-28

Reporting Person: HANCOCK DANIEL M (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-06-28 Common Stock M 9326 $14.35 Acquired 13953 Direct
2021-06-28 Common Stock S 9326 $67.0910 Disposed 4627 Direct
2021-06-29 Common Stock M 100 $14.35 Acquired 4727 Direct
2021-06-29 Common Stock S 100 $67.0318 Disposed 4627 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-06-28 Option to purchase common stock $14.35 M 9326 Disposed 2029-05-02 Common Stock (9326) Direct
2021-06-29 Option to purchase common stock $14.35 M 100 Disposed 2029-05-02 Common Stock (100) Direct

Footnotes

F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2021.

F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.00 to $67.4850, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3: 1/12 of these options vested and became exercisable in equal monthly installments on the 2nd of each month for the next twelve (12) months beginning on 05/02/2019.

F4: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.03 to $67.05, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.